PTC Therapeutics Welcomes Jessica Chutter to Board of Directors, a Move for Future Growth #United_States #PTC_Therapeutics #biotechnology #Warren,_New_Jersey #Jessica_Chutter
PTC Therapeutics Offers Competitive Stock Options to New Employees #USA #PTC_Therapeutics #stock_options #RSUs #Warren,_New_Jersey
PTC Therapeutics Announces Participation in Notable Investor Conferences This March #USA #biopharmaceuticals #PTC_Therapeutics #Warren #Health_Conference
PTC Therapeutics Announces Impressive Financial Performance and Key Updates for 2025 #USA #PTC_Therapeutics #Warren #Sephience #Evrysdi
PTC Therapeutics Takes Step Back on Translarna™ Regulatory Submission Following FDA Feedback #USA #PTC_Therapeutics #Warren #Duchenne_Muscular_Dystrophy #Translarna
PTC Therapeutics Unveils Inducement Grants for New Employee Under Nasdaq Rule #United_States #NASDAQ #PTC_Therapeutics #RSUs #Warren,_New_Jersey
PTC Therapeutics Secures Approval for Sephience in Japan to Treat PKU #Japan #Tokyo #PTC_Therapeutics #Sephience #Phenylketonuria
PTC Therapeutics Announces New Inducement Grants Under Nasdaq Rule to Enhance Employee Compensation #United_States #biopharmaceuticals #PTC_Therapeutics #Warren #NASDAQ_PTCT
PTC Therapeutics to Share Innovations at 44th J.P. Morgan Healthcare Conference #United_States #PTC_Therapeutics #Warren #Matthew_Klein #NASDAQ_PTCT
PTC Therapeutics Announces Stock Option Grants for New Employees Under Nasdaq Rules #United_States #PTC_Therapeutics #stock_options #RSUs #Warren,_N.J.
PTC Therapeutics Announces Upcoming R&D Day for Pipeline Insights #United_States #New_York #PTC_Therapeutics #R&D_Day #pipeline_updates
PTC Therapeutics Reports Strong Third Quarter 2025 Financial Performance and Sephience Launch #United_States #revenue_growth #PTC_Therapeutics #Warren,_New_Jersey #Sephience
PTC Therapeutics' Executives to Showcase Innovations at Significant Investor Conferences #USA #PTC_Therapeutics #Investor_Relations #Healthcare_Conferences #Warren,_New_Jersey
PTC Therapeutics Issues Inducement Stock Options for New Employees #USA #NASDAQ #PTC_Therapeutics #stock_options #Warren
PTC Therapeutics Announces Stock Option Grants for New Employees Under Nasdaq Rules #USA #NASDAQ #PTC_Therapeutics #stock_options #Warren
RareMed Solutions Partners with PTC Therapeutics to Enhance PKU Care with New Services #United_States #Pittsburgh #PTC_Therapeutics #Sephience #RareMed_Solutions
PTC Therapeutics Execs to Showcase Innovations at Major Investor Conferences #United_States #Healthcare_Conference #PTC_Therapeutics #Warren,_N.J. #NASDAQ:PTCT
PTC Therapeutics Faces Setback with FDA Complete Response on Vatiquinone #United_States #PTC_Therapeutics #Warren #Vatiquinone #Friedreich's_Ataxia
PTC Therapeutics Sets the Stage for Growth with Q2 2025 Corporate Update and Financial Performance #USA #financial_results #PTC_Therapeutics #Warren,_NJ #Sephience
Orsini Partners with PTC Therapeutics to Enhance Care for PKU Patients with SEPHIENCE #United_States #Elk_Grove_Village #PTC_Therapeutics #Sephience #Orsini_Pharmacy
Sephience™ Receives EU Approval for Treating PKU in All Ages #None #PTC_Therapeutics #Sephience #Phenylketonuria
PTC Therapeutics Faces Securities Fraud Investigation - Shareholders Can Join #USA #Los_Angeles #Schall_Law_Firm #Securities_Fraud #PTC_Therapeutics
Sephience™ Receives EU Marketing Authorization for PKU Treatment: A Major Leap Forward #None #PTC_Therapeutics #PKU #Sephience
Pomerantz Law Firm Launches Investigation into PTC Therapeutics for Investor Claims #United_States #New_York #PTC_Therapeutics #Pomerantz_Law_Firm #PTCT
PTC Therapeutics Expands Team with New Stock Option Grants for 34 Employees #United_States #biopharmaceuticals #PTC_Therapeutics #stock_options #Warren
PTC Therapeutics Investors Alert: Scrutiny of Securities Practices Unfolds #United_States #New_York #Securities_Fraud #PTC_Therapeutics #Pomerantz_LLP
Pomerantz Law Firm Launches Investigation into PTC Therapeutics Following Significant Stock Plunge #USA #New_York #Securities_Fraud #PTC_Therapeutics #Pomerantz_Law_Firm
Pomerantz Law Firm Launches Investigation for PTC Therapeutics Investors #United_States #New_York #Securities_Fraud #PTC_Therapeutics #Pomerantz_Law_Firm
Pomerantz Law Firm Investigates Potential Securities Fraud at PTC Therapeutics, Inc. #United_States #New_York #Securities_Fraud #PTC_Therapeutics #Pomerantz_LLP
Pomerantz Law Firm Investigates PTC Therapeutics Stock Fraud Allegations for Investors #USA #New_York #PTC_Therapeutics #Pomerantz_LLP #stock_fraud